This inventor holds 2 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1990-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osakasayama, JP (1990)
- Kawachinagano, JP (1997)
Company Filing History:
Years Active: 1990-1997
Title: Innovations of Yukihiro Kuge
Introduction
Yukihiro Kuge is a notable inventor based in Osakasayama, Japan. He has made significant contributions to the field of chemistry, particularly in the production of important compounds. With a total of 2 patents to his name, Kuge's work has implications in various applications, including pharmaceuticals.
Latest Patents
Kuge's latest patents include a process for producing tetrahydroisoquinoline-3-carboxylic acid compounds. This invention involves allowing phenylalanine compounds to react with formaldehyde or paraformaldehyde in the presence of sulfuric acid or hydrobromic acid. The resulting compounds have potential uses in medicinal chemistry. Another significant patent is for the process of producing L(-)-tetrahydrofolic acid. This process utilizes dihydrofolate reductase to act upon dihydrofolic acid in the presence of NADP or NADPH, along with glucose and glucose dehydrogenase. L(-)-tetrahydrofolic acid serves as an important intermediate for L(-)-leucovarin, which is used in various therapeutic applications.
Career Highlights
Yukihiro Kuge is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has allowed him to focus on innovative processes that enhance the production of vital compounds.
Collaborations
Kuge has collaborated with notable coworkers such as Toru Sugaya and Tamotsu Eguchi. Their combined expertise has contributed to the successful development of Kuge's patented processes.
Conclusion
Yukihiro Kuge's contributions to the field of chemistry through his patents demonstrate his innovative spirit and dedication to advancing pharmaceutical science. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
